Paladin Advisory Group’s Colgate-Palmolive CL Stock Holding History

Paladin Advisory Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-72	Closed	-$5K	–	322
2022 Q1	$5K	Buy	+72	New	+$5.7K	﹤0.01%	245

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Paladin Advisory Group's CL Position: Q2 2022 in Review

Paladin Advisory Group sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 72 shares — an estimated $5K sold.

Paladin Advisory Group first reported a position in CL in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

Paladin Advisory Group reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
Paladin Advisory Group sold 72 Colgate-Palmolive shares in Q2 2022, an estimated $5K.
Paladin Advisory Group first reported a position in Colgate-Palmolive in Q1 2022 and held it in 1 quarter.
Paladin Advisory Group's Colgate-Palmolive position peaked at $5K in Q1 2022.
1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Paladin Advisory Group's 13F filing for Q2 2022, filed 6 Jul 2022.